AEON Biopharma, Inc.
Market Cap
$10.53M
P/E Ratio
-0.23
EPS
$-3.95
Dividend Yield
0.00%
52-Week Range
$0.43 — $1.45
Volume
74.04K
Avg Volume
102.26K
Beta
0.73
Get alerted when AEON hits your target price.
Free — enter your email to get started
P/E (TTM)
-0.23
Forward P/E
—
PEG Ratio
0.00
P/S (TTM)
0.00
P/B (TTM)
-0.24
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
1.54%
ROA (TTM)
-7.05%
ROIC
—
Gross Margin
0.00%
Operating Margin
0.00%
Net Margin
—
Debt/Equity
-0.65
Current Ratio
0.49
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+5.85%
EPS Growth (5Y)
+3.42%
Sales Growth (3Y)
+0.00%
Sales Growth (5Y)
-0.25%
EPS Est (This Year)
$-50.40
EPS Est (Next Year)
$-30.24
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.25
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
0
Outstanding Shares
11.83M
Float
8.17M
Free Float %
69.08%
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
AMEX
IPO Date
2023-07-24
Employees
5
CEO
Robert Bancroft
Index Membership
—
Website
http://www.aeonbiopharma.com
AEON Biopharma, Inc. (AEON) is a healthcare company in the biotechnology industry listed on the AMEX. With a market capitalization of $10.53M, a P/E ratio of -0.23, AEON is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare AEON against other stocks using dozens of fundamental and technical filters.
AEON Biopharma, Inc. (AEON) has a trailing twelve-month (TTM) P/E ratio of -0.23. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, AEON Biopharma, Inc. (AEON) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
AEON Biopharma, Inc. (AEON) has a market capitalization of $10.53 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.